NSG 6005 Week 8 Assignment 2 Quiz

NSG 6005 Week 8 Assignment 2 Quiz

NSG 6005 Week 8 Assignment 2 Quiz

1 .Question :

When blood glucose levels are difficult to control in type II diabetes, some form of insulin may be added to the treatment regimen to control blood glucose and limit complications risks .Which of the following statements are accurate based on research?

  • Premixed insulin analogues are better at lowering hemoglobin A1c and have less risk for hypoglycemia .
  • Premixed insulin analogues and the newer premixed insulins are associated with more weight gain than the oral antidiabetic agents .
  • Newer premixed insulins are better at lowering hemoglobin A1c and postprandial glucose levels than are long-acting insulins .
  • Patients who are not controlled on oral agents and have postprandial hyperglycemia can have NPH insulin added at bedtime .

Question 2 .

Lispro is an insulin analogue produced by recombinant deoxyribonucleic acid (DNA) technology .Which of the following statements about this form of insulin is not true?

  • The optimal time of preprandial injection is fifteen minutes .
  • The duration of action is increased when the dose is increased .
  • It is compatible with NPH insulin .
  • It has no pronounced peak .

Question 3 .

Unlike most type II diabetics where obesity is a major issue, older adults with low body weight have higher risks for morbidity and mortality .The most reliable indicator of poor nutritional status in older adults is:

  • Weight loss in previously overweight persons
  • Involuntary loss of 10% of body weight in less than six months
  • Decline in lean body mass over a twelve-month period
  • Increase in central versus peripheral body adiposity

Question 4 .

Sulfonylureas may be added to a treatment regimen for type II diabetics when lifestyle modifications and metformin are insufficient to achieve target glucose levels .Sulfonylureas have been moved to Step 2 therapy because they:

  • Increase endogenous insulin secretion .
  • Have a significant risk for hypoglycemia .
  • Address the insulin resistance found in type II diabetics .
  • Improve insulin binding to receptors .


Question 5 .

The drugs recommended by the American Academy of Pediatrics for use in children with diabetes (depending upon type of diabetes) are:

  • Metformin and insulin
  • Sulfonylureas and insulin glargine
  • Split-mixed dose insulin and GLP-1 agonists
  • Biguanides and insulin lispro